Testicular Germ Cell Tumors Acquire Cisplatin Resistance by Rebalancing the Usage of DNA Repair Pathways.

导出 OA

翻译打印收藏纠错

第一作者： Cinzia,Caggiano

第一单位： Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.

作者： Cinzia,Caggiano ^[1] ; Francesca,Cavallo ^[2] ; Teresa,Giannattasio ^[1] ; Gioia,Cappelletti ^[1] ; Pellegrino,Rossi ^[1] ; Paola,Grimaldi ^[1] ; Darren R,Feldman ^[3] ; Maria,Jasin ^[4] ; Marco,Barchi ^[1]

作者单位： Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy. ^[1] Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.;Developmental Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. ^[2] Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. ^[3] Developmental Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. ^[4]

关键词 53BP1 DNA-PKcs HR NHEJ TGCT cisplatin resistance olaparib (AZD2281)

DOI 10.3390/cancers13040787

PMID 33668653

发布时间 2021-08-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交